In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Neonatology-focused digital diagnostics start-up Astarte Medical raises $5mm through Series A round

Executive Summary

Neonatology-focused Astarte Medical (digital tools and diagnostics to improve pre-term infant outcomes) raised $5mm in a Series A round from backers including Viking Global Investors LP, Lunsford Capital, OCA Ventures, Keiretsu Forum MidAtlantic, Keiretsu Capital Fund, Ben Franklin Technology Partners, Wing VC, and Next Act Fund.
Deal Industry
  • Biotechnology
  • Digital Health
  • In Vitro Diagnostics
  • Medical Devices
    • Diagnostic Equipment & Supplies
    • Monitoring Equipment & Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies

UsernamePublicRestriction

Register